Panel To Rank U.K. Priorities

LONDON—Industrial, government and scientific leaders here are about to launch a new effort to decide how best to spend the U.K.'s research dollars. The tripartite forum—as yet unnamed—is expected to be announced shortly by the government, which hopes to attract a well-known industrialist as its chairman. The idea for such a group came from the government's Advisory Council for Applied Research and Development (ACARD). The Council, a group of senior industrial and government res

Written byDavid Fishlock
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The idea for such a group came from the government's Advisory Council for Applied Research and Development (ACARD). The Council, a group of senior industrial and government research managers, is chaired by Sir Francis Tombs, the chief executive of Rolls-Royce.

The Council has wrestled unsuccessfully with the question of setting priorities for national R&D efforts since the late 1970s. Each time a program cut was considered, noted a former chairman, someone on the Council would rise passionately to its defense and the group would change its mind.

The new forum will spearhead a drive to persuade private industry to spend more on R&D. Greater spending on both in-house and contract research is needed, government officials argue, for Britain to remain competitive with Japan and the United States.

Fairclough believes that Britain needs a substantial and secure core budget for academic science—and, despite the view of many in academia, he said ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies